JP Morgan Chase
MED icon

JP Morgan Chase’s Medifast MED Stock Holding History

JP Morgan Chase’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-311,600
Closed -$43.2M – 5650
2020
Q2 		$43.2M Buy
+311,600
New +$28.6M 0.01% 956
2020
Q1 		– Sell
-11,100
Closed -$1.22M – 5551
2019
Q4 		$1.22M Buy
+11,100
New +$1.07M ﹤0.01% 3714

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase's MED Position: Q2 2026 in Review

JP Morgan Chase increased its Medifast (MED) stake by 6.1% in Q2 2026, buying an estimated $61.5K and bringing the position to 92,512 shares worth $990K. The position accounts for ﹤0.01% of the portfolio, ranked #4678.

JP Morgan Chase first reported a position in MED in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.3M in Q1 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • JP Morgan Chase held 92,512 shares of Medifast worth $990K as of Q2 2026.
  • JP Morgan Chase bought 5,334 Medifast shares in Q2 2026, an estimated $61.5K.
  • Medifast made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4678 holding.
  • JP Morgan Chase first reported a position in Medifast in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Medifast position peaked at $17.3M in Q1 2023.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.